Zhang et al.35found that Gly‐MCA acts as an antagonist to inhibit intestinal FXR, thereby tearing host liver lipid metabolism and improving obesity‐associated metabolic disorders. Here, NR1H4 is linked to obesity due to melanocortin 4 receptor deficiency.